F
Fulcrum Therapeutics, Inc.
FULC · NASDAQ · Healthcare · 285M
Price · close
$3.83
-0.52% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
0.7×
Enterprise value / EBITDAEV/EBITDA
-0.7×
Free cash flow yieldFCF yield
-24.9%
Return on equityROE
-21.5%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
2.6×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.